Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Official title: A Phase III, randomized, double blind, placebo controlled study to evaluate the efficacy and safety of AS012 in subjects with nonsegmental vitiligo
Ages eligible: 18 + years of age
Stipend: Receive compensation for your time and travel of up to $1,670
Location: Brandon, FL
Start Date: Jan 2021
Completion Date: (estimated) Dec 2021
Status: Recruiting
Contact: To learn more about this study, you or your doctor may contact Stanley Katz, MD at 813-948-7550 or visit website MooreCR.com
FAQOther Questions
- What are risks of oral and topical corticosteroids?
Corticosteroid drugs (like hydrocortisone, and others) are often used for treating vitiligo. By mimicing the effects of hormones your body produces naturally in your adrenal gla...
- Which skin conditions can be mistaken for vitiligo?
Vitiligo is a common skin condition with characteristic milky white patches of irregular shape. However, several other skin conditions exhibit similar symptoms that can lead to ...
- Which diseases most commonly accompany vitiligo?
Vitiligo is an autoimmune disease and is frequently associated with other autoimmune diseases, acccording to a 10-year study. The exact diseases that accompany vitiligo can vary...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.